Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everest Re Group Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
Andra AP fonden Sells 59 Shares of Everest Re Group, Ltd. (RE)
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everest Re Group Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
A number of other institutional investors also recently added to or reduced their stakes in RE. BlackRock Inc. boosted its stake in Everest Re Group by 4,778.3% in the first quarter. BlackRock Inc. now owns 3,909,246 shares of the insurance provider’s stock valued at $914,021,000 after buying an additional 3,829,110 shares during the period. Karp Capital Management Corp acquired a new stake in Everest Re Group during the first quarter valued at about $69,686,000. AQR Capital Management LLC boosted its stake in Everest Re Group by 28.9% in the first quarter. AQR Capital Management LLC now owns 1,289,792 shares of the insurance provider’s stock valued at $301,566,000 after buying an additional 289,351 shares during the period. American Century Companies Inc. boosted its stake in Everest Re Group by 190.2% in the second quarter. American Century Companies Inc. now owns 281,630 shares of the insurance provider’s stock valued at $71,700,000 after buying an additional 184,576 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its stake in Everest Re Group by 37.0% in the second quarter. Schwab Charles Investment Management Inc. now owns 466,483 shares of the insurance provider’s stock valued at $118,762,000 after buying an additional 126,065 shares during the period. 91.63% of the stock is owned by institutional investors.
Shares of Everest Re Group, Ltd. (RE) traded up 1.02% on Friday, reaching $260.24. The company had a trading volume of 301,985 shares. The company has a 50 day moving average price of $264.80 and a 200 day moving average price of $248.29. Everest Re Group, Ltd. has a 52-week low of $183.04 and a 52-week high of $277.17. The stock has a market capitalization of $10.69 billion, a PE ratio of 8.93 and a beta of 0.63.
Everest Re Group (NYSE:RE) last issued its quarterly earnings data on Monday, July 24th. The insurance provider reported $5.51 EPS for the quarter, topping analysts’ consensus estimates of $5.24 by $0.27. Everest Re Group had a net margin of 19.65% and a return on equity of 13.60%. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.46 billion. During the same period last year, the business posted $3.17 earnings per share. On average, equities research analysts anticipate that Everest Re Group, Ltd. will post $21.33 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 20th. Investors of record on Wednesday, September 6th will be issued a dividend of $1.25 per share. The ex-dividend date is Friday, September 1st. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.92%. Everest Re Group’s payout ratio is 17.15%.
WARNING: “[[title]]” was first published by [[site]] and is owned by of [[site]]. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at [[permalink]].
RE has been the topic of several analyst reports. Keefe, Bruyette & Woods cut Everest Re Group from a “market perform” rating to an “underperform” rating and decreased their price objective for the stock from $251.00 to $245.00 in a report on Monday, July 17th. Deutsche Bank AG restated a “buy” rating and set a $262.00 price objective (up previously from $240.00) on shares of Everest Re Group in a report on Saturday, April 29th. Zacks Investment Research upgraded Everest Re Group from a “hold” rating to a “buy” rating and set a $293.00 price objective on the stock in a report on Friday, July 7th. Morgan Stanley restated an “equal weight” rating and set a $259.00 price objective (up previously from $250.00) on shares of Everest Re Group in a report on Thursday, July 6th. Finally, Wells Fargo & Company restated a “hold” rating on shares of Everest Re Group in a report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, six have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $250.25.
About Everest Re Group
Everest Re Group, Ltd., through its subsidiaries, is engaged in the underwriting of reinsurance and insurance in the United States, Bermuda and international markets. The Company operates in segments: U.S. Reinsurance, International, Bermuda and Insurance segment. The Company underwrites reinsurance both through brokers and directly with ceding companies.
Want to see what other hedge funds are holding RE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everest Re Group, Ltd. (NYSE:RE).